Annual Results Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
903.68
924.68
916.91
881.63
844.66
376.97
Shareholder's Funds
903.68
924.68
916.91
881.63
844.66
376.97
Minority Interest
0.30
8.82
13.86
10.22
0.00
0.00
Long-Term Borrowings
425.77
361.15
233.18
129.80
35.00
25.00
Secured Loans
425.77
361.15
233.18
129.80
35.00
25.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-16.51
-15.75
-11.36
-7.00
-4.81
0.00
Other Long Term Liabilities
29.14
3.63
8.35
11.69
6.89
5.33
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
13.48
0.53
1.21
0.09
1.33
2.84
Total Non-Current Liabilities
352.85
253.16
185.64
41.68
6.89
5.33
Current Liabilities
Trade Payables
153.07
86.29
40.06
75.87
34.28
33.08
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
13.48
0.53
1.21
0.09
1.33
2.84
Total Current Liabilities
737.07
595.59
476.22
525.23
341.66
239.83
Total Liabilities
2,023.07
1,807.04
1,612.61
1,478.87
1,211.88
641.26
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
845.96
756.31
611.08
514.72
388.89
334.94
Less: Accumulated Depreciation
215.07
183.45
156.32
131.12
107.80
88.40
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
630.89
572.87
454.76
383.60
281.09
246.54
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Assets
1,026.74
898.90
681.42
542.98
336.91
278.50
Current Assets Loans & Advances
Current Investments
2.60
17.50
0.00
90.00
200.00
10.00
Inventories
62.38
85.68
72.12
78.52
74.50
46.00
Sundry Debtors
655.97
570.35
491.55
491.69
342.52
192.26
Cash and Bank
246.61
224.16
362.07
269.23
254.37
103.98
Other Current Assets
970.14
898.70
926.83
933.23
872.49
353.04
Short Term Loans and Advances
2.58
1.00
1.10
3.78
1.10
0.81
Total Current Assets
996.33
908.14
931.19
935.89
874.98
362.76
Net Current Assets (Including Current Investments)
259.26
312.55
454.97
410.67
533.31
122.93
Total Current Assets Excluding Current Investments
996.33
908.14
931.19
935.89
874.98
362.76
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
2,023.07
1,807.04
1,612.61
1,478.87
1,211.88
641.26
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
425.77
361.15
233.18
129.80
35.00
25.00
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of Chengdu Olymvax Biopharmaceuticals, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(CNY)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
903.68
0
903.68
0.00%
Shareholder's Funds
903.68
0
903.68
0.00%
Minority Interest
0.30
0
0.30
0.00%
Long-Term Borrowings
425.77
0
425.77
0.00%
Secured Loans
425.77
0
425.77
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-16.51
0
-16.51
0.00%
Other Long Term Liabilities
29.14
0
29.14
0.00%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
13.48
0
13.48
0.00%
Total Non-Current Liabilities
352.85
0
352.85
0.00%
Current Liabilities
Trade Payables
153.07
0
153.07
0.00%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
13.48
0
13.48
0.00%
Total Current Liabilities
737.07
0
737.07
0.00%
Total Liabilities
2,023.07
0
2,023.07
0.00%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
845.96
0
845.96
0.00%
Less: Accumulated Depreciation
215.07
0
215.07
0.00%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
630.89
0
630.89
0.00%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
0
0.00
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0
0.00
0.00%
Total Non-Current Assets
1,026.74
0
1,026.74
0.00%
Current Assets Loans & Advances
Current Investments
2.60
0
2.60
0.00%
Inventories
62.38
0
62.38
0.00%
Sundry Debtors
655.97
0
655.97
0.00%
Cash and Bank
246.61
0
246.61
0.00%
Other Current Assets
970.14
0
970.14
0.00%
Short Term Loans and Advances
2.58
0
2.58
0.00%
Total Current Assets
996.33
0
996.33
0.00%
Net Current Assets (Including Current Investments)
259.26
0
259.26
0.00%
Total Current Assets Excluding Current Investments
996.33
0
996.33
0.00%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
2,023.07
0
2,023.07
0.00%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
425.77
0
425.77
0.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
